Anthony Edward Dobranowski

Anthony Edward Dobranowski discloses dealings in Crescita Therapeutics Inc. to SEDI. Altogether 2 filings, all relating to 3 June 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 8 June 2026: a transaction of €47k, in Crescita Therapeutics Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.